Medpace Holdings (MEDP) Tax Rate (2015 - 2026)
Medpace Holdings' (MEDP) quarterly Tax Rate came in at 19.98% in Q2 2026, down 754.0% on a YoY basis from 3.05% in Q2 2025, and up 24.31% quarter-over-quarter from 16.07% in Q1 2026.
Analysis
Medpace Holdings (MEDP) Tax Rate (2015 - 2026) Analysis & Trends
Medpace Holdings (MEDP) has reported Tax Rate for 12 consecutive years, with 19.98% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Tax Rate fell 754.0% year-over-year to 19.98%; the trailing twelve-month figure through Jun 2026 stood at 17.94% (up 238.0% YoY), and the FY2025 full-year result was 16.82%, up 179.0% from the prior year.
- Tax Rate advanced to 19.98% in Q2 2026 per MEDP's latest filing, from 16.07% in the prior quarter.
- Across five years, Tax Rate topped out at 27.52% in Q2 2025 and bottomed at 3.03% in Q1 2025.
- Historically, Tax Rate has averaged 15.52% across 5 years, with a median of 15.67% in 2023.
- The sharpest annual moves came in 2022 and 2026: Tax Rate surged 1394 bps in 2022, then slumped 754 bps in 2026.
- Over 5 years, Tax Rate stood at 6.76% in 2022, then soared by 103 bps to 13.68% in 2023, then fell by 8 bps to 12.6% in 2024, then increased by 10 bps to 13.84% in 2025, then jumped by 44 bps to 19.98% in 2026.
- According to Business Quant data, Tax Rate over the past three periods registered 19.98%, 16.07%, and 13.84% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 19.93% |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 19.98% |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | -21.28% |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 101.43% |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | -1,000.00% |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | -0.22% |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | -2.65% |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | 2.58% |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | -0.11% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 19.98% |
| Mar 31, 2026 | 16.07% |
| Dec 31, 2025 | 13.84% |
| Sep 30, 2025 | 22.19% |
| Jun 30, 2025 | 27.52% |
| Mar 31, 2025 | 3.03% |
| Dec 31, 2024 | 12.60% |
| Sep 30, 2024 | 18.82% |
| Jun 30, 2024 | 20.03% |
| Mar 31, 2024 | 9.04% |
| Dec 31, 2023 | 13.68% |
| Sep 30, 2023 | 15.21% |
| Jun 30, 2023 | 19.38% |
| Mar 31, 2023 | 15.27% |
| Dec 31, 2022 | 6.76% |
| Sep 30, 2022 | 19.37% |
| Jun 30, 2022 | 20.39% |
| Mar 31, 2022 | 6.14% |
| Dec 31, 2021 | 10.53% |
| Sep 30, 2021 | 11.26% |